Date published: 2026-3-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

5,7-Dichlorokynurenic acid (CAS 131123-76-7)

0.0(0)
Write a reviewAsk a question

Application:
5,7-Dichlorokynurenic acid is a potent NMDA receptor glycine binding site antagonist
CAS Number:
131123-76-7
Molecular Weight:
258.06
Molecular Formula:
C10H5Cl2NO3
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

5,7-Dichlorokynurenic acid is a derivative of the excitatory amino acid kynurenic acid and an antagonist of the strychnine-insensitive glycine modulatory (co-agonist) binding site on the NMDA receptor. 5,7-Dichlorokynurenic acid is described to potently and noncompetitively antagonize NMDA-stimulated elevation of cytosolic Ca2+, accumulation of cGMP, and release of norepinephrine. 5,7-Dichlorokynurenic acid is an inhibitor of GluR.


5,7-Dichlorokynurenic acid (CAS 131123-76-7) References

  1. Synthesis and SAR of novel di- and trisubstituted 1,4-dihydroquinoxaline-2,3-diones related to licostinel (Acea 1021) as NMDA/glycine site antagonists.  |  Zhou, ZL., et al. 2003. Bioorg Med Chem. 11: 1769-80. PMID: 12659763
  2. Schwann cells exhibit excitotoxicity consistent with release of NMDA receptor agonists.  |  Wu, SZ., et al. 2005. J Neurosci Res. 79: 638-43. PMID: 15672444
  3. Kynurenic acid derivatives. Structure-activity relationships for excitatory amino acid antagonism and identification of potent and selective antagonists at the glycine site on the N-methyl-D-aspartate receptor.  |  Leeson, PD., et al. 1991. J Med Chem. 34: 1243-52. PMID: 1826744
  4. Intracisternal administration of NR2 antagonists attenuates facial formalin-induced nociceptive behavior in rats.  |  Yang, GY., et al. 2010. J Orofac Pain. 24: 203-11. PMID: 20401359
  5. Activity of 5,7-dichlorokynurenic acid, a potent antagonist at the N-methyl-D-aspartate receptor-associated glycine binding site.  |  Baron, BM., et al. 1990. Mol Pharmacol. 38: 554-61. PMID: 2172769
  6. Centrally-administered glycine antagonists increase locomotion in monoamine-depleted mice.  |  Stauch Slusher, B., et al. 1994. J Neural Transm Gen Sect. 97: 175-85. PMID: 7873128
  7. Molecular biological studies on nuclear transcription factors expressed through the N-methyl-D-aspartate receptor complex.  |  Yoneda, Y. and Ogita, K. 1994. Nihon Shinkei Seishin Yakurigaku Zasshi. 14: 255-67. PMID: 7975930
  8. Differential profiles of binding of a radiolabeled agonist and antagonist at a glycine recognition domain on the N-methyl-D-aspartate receptor ionophore complex in rat brain.  |  Yoneda, Y., et al. 1994. J Neurochem. 62: 102-12. PMID: 8263509
  9. Support for radiolabeling of a glycine recognition domain on the N-methyl-D-aspartate receptor ionophore complex by 5,7-[3H]dichlorokynurenate in rat brain.  |  Yoneda, Y., et al. 1993. J Neurochem. 60: 634-45. PMID: 8419541
  10. Activation of N-methyl-D-aspartate receptors by glycine: role of an aspartate residue in the M3-M4 loop of the NR1 subunit.  |  Williams, K., et al. 1996. Mol Pharmacol. 50: 701-8. PMID: 8863813
  11. Effects of felbamate on veratridine- and K(+)-stimulated release of glutamate from mouse cortex.  |  Srinivasan, J., et al. 1996. Eur J Pharmacol. 315: 285-8. PMID: 8982666
  12. Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline.  |  Witkin, JM., et al. 1997. J Pharmacol Exp Ther. 280: 46-52. PMID: 8996180
  13. Glycine site antagonists and partial agonists inhibit N-methyl-D-aspartate receptor-mediated [3H]arachidonic acid release in cerebellar granule cells.  |  Viu, E., et al. 1998. J Pharmacol Exp Ther. 285: 527-32. PMID: 9580593

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

5,7-Dichlorokynurenic acid, 10 mg

sc-200440
10 mg
$74.00

5,7-Dichlorokynurenic acid, 50 mg

sc-200440A
50 mg
$409.00